Literature DB >> 20510914

[Medication adherence of a sample of hypertensive patients in the region of Sfax (Tunisia)].

H Ghozzi1, M Kassis, A Hakim, Z Sahnoun, A Abderrahmen, R Abbes, S Maalej, S Hammami, L Hajkacem, K Zeghal.   

Abstract

THE AIM OF THE STUDY: Medication noncompliance is one of the daily problems of the physician. Improving the medication adherence allows better management of hypertension. The aim of this work was to determine the level of compliance for patients with hypertension and to identify factors that determine compliance.
METHODS: A cross-sectional study was carried out among a sample of hypertensive patients attending general and specialist practitioners in public or private clinics of Sfax. Two hundred and seventy-three participants had accepted to be interviewed. Patients were identified as noncompliants using a questionnaire developed by the Comité de lutte contre l'hypertension artérielle (CFLHTA).
RESULTS: Non-compliance rate was 63.4%. The low level of education was associated with a lower adherence. The monotherapy, the once-daily regimen with fewer number of tablets were associated with a better adherence (p<10(-6)). The welcome and the availability of drugs in the public clinic affect positively the adherence of patients (p<0.0002). A patient very satisfied with his consultation and the explanation given by the doctor about his illness and its treatment had a better adherence (p<0.00003).
CONCLUSION: Our study had demonstrated a low compliance with antihypertensive drug therapy. Tunisian health care system should elaborate a management plan which takes into account our particular predictors of compliance to improve adherence to antihypertensive medication. Copyright 2010 Elsevier Masson SAS. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20510914     DOI: 10.1016/j.ancard.2010.04.004

Source DB:  PubMed          Journal:  Ann Cardiol Angeiol (Paris)        ISSN: 0003-3928


  7 in total

1.  Epidemiology of arterial hypertension in Tunisia: Hammam Sousse Sahloul Heart Study (HSHS).

Authors:  Aicha Hamoudi; Asma Ben Abdelaziz; Sarra Melki; Donia Ben Hassine; Nabila Ben Rejeb; Asma Omezzine; Ali Bouslama; Ahmed Ben Abdelaziz
Journal:  Tunis Med       Date:  2022 fevrier

2.  Analyzing recent coronary heart disease mortality trends in Tunisia between 1997 and 2009.

Authors:  Olfa Saidi; Nadia Ben Mansour; Martin O'Flaherty; Simon Capewell; Julia A Critchley; Habiba Ben Romdhane
Journal:  PLoS One       Date:  2013-05-03       Impact factor: 3.240

3.  Predictors of non-adherence to antihypertensive medication in Kinshasa, Democratic Republic of Congo: a cross-sectional study.

Authors:  Aimée M Lulebo; Paulin B Mutombo; Mala A Mapatano; Eric M Mafuta; Patrick K Kayembe; Lisa T Ntumba; Alain N Mayindu; Yves Coppieters
Journal:  BMC Res Notes       Date:  2015-10-01

4.  [Drug compliance and its factors in a group of hypertensive Congolese].

Authors:  Méo Stéphane Ikama; Bernice Mesmer Nsitou; Mpouoni Loumouamou; Gisèle Kimbally-Kaky; Jean Louis Nkoua
Journal:  Pan Afr Med J       Date:  2013-08-06

Review 5.  Nonadherence to antihypertensive drugs: A systematic review and meta-analysis.

Authors:  Tadesse Melaku Abegaz; Abdulla Shehab; Eyob Alemayehu Gebreyohannes; Akshaya Srikanth Bhagavathula; Asim Ahmed Elnour
Journal:  Medicine (Baltimore)       Date:  2017-01       Impact factor: 1.889

6.  Factors associated with poor medication adherence during COVID-19 pandemic among hypertensive patients visiting public hospitals in Eastern Ethiopia: a cross-sectional study.

Authors:  Lemesa Abdisa; Addisu Alemu; Helina Heluf; Addisu Sertsu; Yadeta Dessie; Belay Negash; Galana Mamo Ayana; Shiferaw Letta
Journal:  BMJ Open       Date:  2022-10-06       Impact factor: 3.006

7.  Prevalence and Associated Factors of Compliance Behaviors among Middle-Aged and Older Hypertensive Patients in China: Results from the China Health and Retirement Longitudinal Study.

Authors:  Jianjian Liu; Ying Yang; Jiayi Zhou; Tianyu Liu; Wenjie Zhang; Liuyi Wei; Shaotang Wu
Journal:  Int J Environ Res Public Health       Date:  2020-10-08       Impact factor: 3.390

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.